Global Active Pharmaceutical Ingredients (API) Market Research Report 2020
Table of Contents1 Active Pharmaceutical Ingredients (API) Market Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients (API)
1.2 Active Pharmaceutical Ingredients (API) Segment by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Active Pharmaceutical Ingredients (API) Segment by Application
1.3.1 Active Pharmaceutical Ingredients (API) Consumption Comparison by Application: 2020 VS 2026
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Global Active Pharmaceutical Ingredients (API) Market by Region
1.4.1 Global Active Pharmaceutical Ingredients (API) Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Global Active Pharmaceutical Ingredients (API) Growth Prospects
1.5.1 Global Active Pharmaceutical Ingredients (API) Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Active Pharmaceutical Ingredients (API) Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts (2015-2026)
2 Market Competition by Manufacturers
2.1 Global Active Pharmaceutical Ingredients (API) Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2015-2020)
2.5 Manufacturers Active Pharmaceutical Ingredients (API) Production Sites, Area Served, Product Types
2.6 Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends
2.6.1 Active Pharmaceutical Ingredients (API) Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Active Pharmaceutical Ingredients (API) Market Share by Regions (2015-2020)
3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions (2015-2020)
3.3 Global Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America Active Pharmaceutical Ingredients (API) Production
3.4.1 North America Active Pharmaceutical Ingredients (API) Production Growth Rate (2015-2020)
3.4.2 North America Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Active Pharmaceutical Ingredients (API) Production
3.5.1 Europe Active Pharmaceutical Ingredients (API) Production Growth Rate (2015-2020)
3.5.2 Europe Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China Active Pharmaceutical Ingredients (API) Production
3.6.1 China Active Pharmaceutical Ingredients (API) Production Growth Rate (2015-2020)
3.6.2 China Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Japan Active Pharmaceutical Ingredients (API) Production
3.7.1 Japan Active Pharmaceutical Ingredients (API) Production Growth Rate (2015-2020)
3.7.2 Japan Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global Active Pharmaceutical Ingredients (API) Consumption by Regions
4.1 Global Active Pharmaceutical Ingredients (API) Consumption by Regions
4.1.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region
4.1.2 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Region
4.2 North America
4.2.1 North America Active Pharmaceutical Ingredients (API) Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Active Pharmaceutical Ingredients (API) Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Active Pharmaceutical Ingredients (API) Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil
5 Production, Revenue, Price Trend by Type
5.1 Global Active Pharmaceutical Ingredients (API) Production Market Share by Type (2015-2020)
5.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2015-2020)
5.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2015-2020)
5.4 Global Active Pharmaceutical Ingredients (API) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
6 Global Active Pharmaceutical Ingredients (API) Market Analysis by Application
6.1 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020)
6.2 Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Application (2015-2020)
7 Company Profiles and Key Figures in Active Pharmaceutical Ingredients (API) Business
7.1 Teva
7.1.1 Teva Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.1.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.1.3 Teva Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Main Business and Markets Served
7.2 Mylan
7.2.1 Mylan Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.2.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.2.3 Mylan Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 Main Business and Markets Served
7.3 DSM
7.3.1 DSM Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.3.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.3.3 DSM Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Main Business and Markets Served
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.4.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Main Business and Markets Served
7.5 Aspen
7.5.1 Aspen Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.5.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.5.3 Aspen Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Main Business and Markets Served
7.6 Novartis
7.6.1 Novartis Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.6.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.6.3 Novartis Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 Main Business and Markets Served
7.7 BASF
7.7.1 BASF Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.7.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.7.3 BASF Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Main Business and Markets Served
7.8 Pfizer
7.8.1 Pfizer Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.8.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.8.3 Pfizer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.8.4 Main Business and Markets Served
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.9.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.9.4 Main Business and Markets Served
7.10 Hisun Pharmaceutical
7.10.1 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.10.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.10.4 Main Business and Markets Served
7.11 Sun Pharmaceutical Industries
7.11.1 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.11.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.11.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.11.4 Main Business and Markets Served
7.12 Zhejiang Medicine
7.12.1 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.12.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.12.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.12.4 Main Business and Markets Served
7.13 Dr. Reddy's Laboratories
7.13.1 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.13.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.13.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.13.4 Main Business and Markets Served
7.14 Zhejiang NHU
7.14.1 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.14.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.14.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.14.4 Main Business and Markets Served
7.15 Bayer
7.15.1 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.15.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.15.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.15.4 Main Business and Markets Served
7.16 NCPC
7.16.1 Bayer Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.16.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.16.3 Bayer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.16.4 Main Business and Markets Served
7.17 AbbVie
7.17.1 NCPC Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.17.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.17.3 NCPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.17.4 Main Business and Markets Served
7.18 Shandong Xinhua Pharmaceutical
7.18.1 AbbVie Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.18.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.18.3 AbbVie Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.18.4 Main Business and Markets Served
7.19 Northeast Pharm
7.19.1 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.19.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.19.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.19.4 Main Business and Markets Served
7.20 Harbin Pharmaceutical
7.20.1 Northeast Pharm Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.20.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.20.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.20.4 Main Business and Markets Served
7.21 LKPC
7.21.1 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
7.21.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
7.21.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.21.4 Main Business and Markets Served
.1 LKPC Active Pharmaceutical Ingredients (API) Production Sites and Area Served
.2 Active Pharmaceutical Ingredients (API) Product Introduction, Application and Specification
.3 LKPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
.4 Main Business and Markets Served
8 Active Pharmaceutical Ingredients (API) Manufacturing Cost Analysis
8.1 Active Pharmaceutical Ingredients (API) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
8.4 Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Active Pharmaceutical Ingredients (API) Distributors List
9.3 Active Pharmaceutical Ingredients (API) Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis
11 Production and Supply Forecast
11.1 Global Forecasted Production of Active Pharmaceutical Ingredients (API) (2021-2026)
11.2 Global Forecasted Revenue of Active Pharmaceutical Ingredients (API) (2021-2026)
11.3 Global Forecasted Price of Active Pharmaceutical Ingredients (API) (2021-2026)
11.4 Global Active Pharmaceutical Ingredients (API) Production Forecast by Regions (2021-2026)
11.4.1 North America Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2021-2026)
11.4.2 Europe Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2021-2026)
11.4.3 China Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2021-2026)
11.4.4 Japan Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2021-2026)
12 Consumption and Demand Fprecast
12.1 Global Forecasted and Consumption Demand Analysis of Active Pharmaceutical Ingredients (API)
12.2 North America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
12.3 Europe Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
12.4 Asia Pacific Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Regions
12.5 Latin America Forecasted Consumption of Active Pharmaceutical Ingredients (API)
13 Forecast by Type and by Application (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of Active Pharmaceutical Ingredients (API) by Type (2021-2026)
13.1.2 Global Forecasted Revenue of Active Pharmaceutical Ingredients (API) by Type (2021-2026)
13.1.2 Global Forecasted Price of Active Pharmaceutical Ingredients (API) by Type (2021-2026)
13.2 Global Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Application (2021-2026)
14 Reseach Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of TablesTable 1. Global Active Pharmaceutical Ingredients (API) Production (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Active Pharmaceutical Ingredients (API) Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 3. Global Active Pharmaceutical Ingredients (API) Consumption (K MT) Comparison by Application: 2020 VS 2026
Table 4. Global Active Pharmaceutical Ingredients (API) Production (K MT) by Manufacturers
Table 5. Global Active Pharmaceutical Ingredients (API) Production (K MT) by Manufacturers (2015-2020)
Table 6. Global Active Pharmaceutical Ingredients (API) Production Share by Manufacturers (2015-2020)
Table 7. Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2015-2020)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2019)
Table 10. Global Market Active Pharmaceutical Ingredients (API) Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 11. Manufacturers Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 12. Manufacturers Active Pharmaceutical Ingredients (API) Product Types
Table 13. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14.Mergers & Acquisitions, Expansion
Table 15. Global Active Pharmaceutical Ingredients (API) Capacity (K MT) by Region (2015-2020)
Table 16. Global Active Pharmaceutical Ingredients (API) Production (K MT) by Region (2015-2020)
Table 17. Global Active Pharmaceutical Ingredients (API) Revenue (Million US$) by Region (2015-2020)
Table 18. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2015-2020)
Table 19. Global Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 20. North America Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 21. Europe Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 22. China Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 23. Japan Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 24. Global Active Pharmaceutical Ingredients (API) Consumption (K MT) Market by Region (2015-2020)
Table 25. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Region (2015-2020)
Table 26. North America Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT)
Table 27. Europe Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT)
Table 28. Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT)
Table 29. Latin America Active Pharmaceutical Ingredients (API) Consumption by Countries (2015-2020) (K MT)
Table 30. Global Active Pharmaceutical Ingredients (API) Production (K MT) by Type (2015-2020)
Table 31. Global Active Pharmaceutical Ingredients (API) Production Share by Type (2015-2020)
Table 32. Global Active Pharmaceutical Ingredients (API) Revenue (Million US$) by Type (2015-2020)
Table 33. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2015-2020)
Table 34. Global Active Pharmaceutical Ingredients (API) Price (USD/MT) by Type (2015-2020)
Table 35. Global Active Pharmaceutical Ingredients (API) Consumption (K MT) by Application (2015-2020)
Table 36. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2015-2020)
Table 37. Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Application (2015-2020)
Table 38. Teva Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 39. Teva Production Sites and Area Served
Table 40. Teva Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 41. Teva Main Business and Markets Served
Table 42. Mylan Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 43. Mylan Production Sites and Area Served
Table 44. Mylan Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 45. Mylan Main Business and Markets Served
Table 46. DSM Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 47. DSM Production Sites and Area Served
Table 48. DSM Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 49. DSM Main Business and Markets Served
Table 50. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 51. Aurobindo Pharma Production Sites and Area Served
Table 52. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 53. Aurobindo Pharma Main Business and Markets Served
Table 54. Aspen Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 55. Aspen Production Sites and Area Served
Table 56. Aspen Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 57. Aspen Main Business and Markets Served
Table 58. Novartis Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 59. Novartis Production Sites and Area Served
Table 60. Novartis Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Novartis Main Business and Markets Served
Table 62. BASF Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 63. BASF Production Sites and Area Served
Table 64. BASF Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 65. BASF Main Business and Markets Served
Table 66. Pfizer Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 67. Pfizer Production Sites and Area Served
Table 68. Pfizer Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 69. Pfizer Main Business and Markets Served
Table 70. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 71. Huahai Pharmaceutical Production Sites and Area Served
Table 72. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Huahai Pharmaceutical Main Business and Markets Served
Table 74. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 75. Hisun Pharmaceutical Production Sites and Area Served
Table 76. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Hisun Pharmaceutical Main Business and Markets Served
Table 78. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 79. Sun Pharmaceutical Industries Production Sites and Area Served
Table 80. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Sun Pharmaceutical Industries Main Business and Markets Served
Table 82. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 83. Zhejiang Medicine Production Sites and Area Served
Table 84. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Zhejiang Medicine Main Business and Markets Served
Table 86. Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 87. Dr. Reddy's Laboratories Production Sites and Area Served
Table 88. Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Dr. Reddy's Laboratories Main Business and Markets Served
Table 90. Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 91. Zhejiang NHU Production Sites and Area Served
Table 92. Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Zhejiang NHU Main Business and Markets Served
Table 94. Bayer Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 95. Bayer Production Sites and Area Served
Table 96. Bayer Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Bayer Main Business and Markets Served
Table 98. NCPC Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 99. NCPC Production Sites and Area Served
Table 100. NCPC Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. NCPC Main Business and Markets Served
Table 102. AbbVie Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 103. AbbVie Production Sites and Area Served
Table 104. AbbVie Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. AbbVie Main Business and Markets Served
Table 106. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 107. Shandong Xinhua Pharmaceutical Production Sites and Area Served
Table 108. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Shandong Xinhua Pharmaceutical Main Business and Markets Served
Table 110. Northeast Pharm Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 111. Northeast Pharm Production Sites and Area Served
Table 112. Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Northeast Pharm Main Business and Markets Served
Table 114. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 115. Harbin Pharmaceutical Production Sites and Area Served
Table 116. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Harbin Pharmaceutical Main Business and Markets Served
Table 118. LKPC Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 119. LKPC Production Sites and Area Served
Table 120. LKPC Active Pharmaceutical Ingredients (API) Production Capacity (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. LKPC Main Business and Markets Served
Table 122. Production Base and Market Concentration Rate of Raw Material
Table 123. Key Suppliers of Raw Materials
Table 124. Active Pharmaceutical Ingredients (API) Distributors List
Table 125. Active Pharmaceutical Ingredients (API) Customers List
Table 126. Market Key Trends
Table 127. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 128. Key Challenges
Table 129. Global Active Pharmaceutical Ingredients (API) Production (K MT) Forecast by Region (2021-2026)
Table 130. North America Active Pharmaceutical Ingredients (API) Consumption Forecast 2021-2026 (K MT) by Country
Table 131. Europe Active Pharmaceutical Ingredients (API) Consumption Forecast 2021-2026 (K MT) by Country
Table 132. Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Forecast 2021-2026 (K MT) by Regions
Table 133. Latin America Active Pharmaceutical Ingredients (API) Consumption Forecast 2021-2026 (K MT) by Country
Table 134. Global Active Pharmaceutical Ingredients (API) Consumption (K MT) Forecast by Regions (2021-2026)
Table 135. Global Active Pharmaceutical Ingredients (API) Production (K MT) Forecast by Type (2021-2026)
Table 136. Global Active Pharmaceutical Ingredients (API) Revenue (Million US$) Forecast by Type (2021-2026)
Table 137. Global Active Pharmaceutical Ingredients (API) Price (USD/MT) Forecast by Type (2021-2026)
Table 138. Global Active Pharmaceutical Ingredients (API) Consumption (K MT) Forecast by Application (2021-2026)
Table 139.Research Programs/Design for This Report
Table 140.Key Data Information from Secondary Sources
Table 141.Key Data Information from Primary Sources
List of FiguresFigure 1. Picture of Active Pharmaceutical Ingredients (API)
Figure 2. Global Active Pharmaceutical Ingredients (API) Production Market Share by Type: 2020 VS 2026
Figure 3. Synthetic APIs Product Picture
Figure 4. Biotech APIs Product Picture
Figure 5. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application: 2020 VS 2026
Figure 6. CNS
Figure 7. Cardiovascular
Figure 8. Genitourinary/Hormonal Drugs
Figure 9. Respiratory
Figure 10. Rheumatology
Figure 11. Diabetes
Figure 12. Oncology
Figure 13. Others
Figure 14. North America Active Pharmaceutical Ingredients (API) Revenue (Million US$) and Growth Rate (2015-2026)
Figure 15. Europe Active Pharmaceutical Ingredients (API) Revenue (Million US$) and Growth Rate (2015-2026)
Figure 16. China Active Pharmaceutical Ingredients (API) Revenue (Million US$) and Growth Rate (2015-2026)
Figure 17. Japan Active Pharmaceutical Ingredients (API) Revenue (Million US$) and Growth Rate (2015-2026)
Figure 18. Global Active Pharmaceutical Ingredients (API) Revenue (Million US$) (2015-2026)
Figure 19. Global Active Pharmaceutical Ingredients (API) Production Capacity (K MT) (2015-2026)
Figure 20. Active Pharmaceutical Ingredients (API) Production Share by Manufacturers in 2019
Figure 21. Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers in 2019
Figure 22. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Market Active Pharmaceutical Ingredients (API) Average Price (USD/MT) of Key Manufacturers in 2019
Figure 24. The Global 5 and 10 Largest Players: Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2019
Figure 25. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2015-2020)
Figure 26. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region in 2019
Figure 27. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2015-2020)
Figure 28. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in 2019
Figure 29. Global Active Pharmaceutical Ingredients (API) Production (K MT) Growth Rate (2015-2020)
Figure 30. North America Active Pharmaceutical Ingredients (API) Production (K MT) Growth Rate (2015-2020)
Figure 31. Europe Active Pharmaceutical Ingredients (API) Production (K MT) Growth Rate (2015-2020)
Figure 32. China Active Pharmaceutical Ingredients (API) Production (K MT) Growth Rate (2015-2020)